1 unknown, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
Follow MET-2: new trials by email Literature Review of MET-2 trials Research Report on MET-2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation MET-2, Placebo - Gram-negative Bacteremia, Microbial Colonization | Phase 2 | Withdrawn | University Health Network, Toronto | 2026-07-01 | 2026-03-12 | |
| The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression MET-2, Placebo - Major Depressive Disorder, Anxiety | Phase 2 | Unknown | NuBiyota | 60 | 2021-04-01 | 2021-05-11 |
Anxiety Disorders (1) · Bacteremia (1) · Communicable Diseases (1) · Depressive Disorder, Major (1) · Infections (1)
NuBiyota (1) · University Health Network, Toronto (1)
Canada (2)
Bryan Coburn, MD, PhD (1) · Roumen Milev, MD/PhD (1)